Most Recent
The lead plaintiff in a class action alleging police conducted thousands of unlawful strip searches at music festivals in NSW has sought $130,000 in damages on the first day of trial against the state.
Construction PRO
Woodside is facing another legal challenge to its $16.5 billion Scarborough gas project, in what an environmental group called a "test case" for how NOPSEMA will assess greenhouse gas emissions from energy projects.
Construction PRO
A stay of a $37 million 2023 judgment in favour of the company behind an abandoned $185 million development in Gosford NSW against the Australian arm of China's Shanxi Construction Investment Group has been extended.
Construction PRO
Clive Palmer's Mineralogy can access the content of email inboxes of two senior executives at engineering firm CITIC in a feud over the $12 billion Sino Iron project in Western Australia’s Pilbara region.
Construction PRO
In the latest expansion of its energy, infrastructure and resources team, K&L Gates has lured the former co-head of Baker McKenzie's Australia energy group to join the firm.
Seven has gone on the offensive in a lawsuit by former Spotlight producer Taylor Auerbach that alleges the broadcaster breached a settlement deed and defamed him, arguing it was Auerbach who broke the terms of their agreement.
A judge has signed off on a settlement in a class action by investors in failed advisory firm Linchpin Capital, with insurer AIG paying $12.15 million and forfeiting its right to appeal a liability finding.
A judge has said Sydney firm Atanskovic Hartnell’s garnishee order was “entirely unacceptable” in a long-running fee fight with its former client, a company owned by media mogul Bruce Gordon.
Alcoa has won a transfer pricing dispute with the Tax Office, with a tribunal rejecting the ATO's novel argument that Alcoa was not dealing at arm's length in selling alumina to a distributor that bribed Bahraini government officials.
Biopharmaceutical company Amgen has lodged proceedings against generic maker Sandoz, calling for documents related to regulatory approval of a generic version of its top-selling bone disease treatments.